Cargando…
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
INTRODUCTION: Osteopontin (OPN) has been implicated as a mediator of Th17 regulation via type I interferon (IFN) receptor signaling and in macrophage activity at sites of tissue repair. This study assessed whether increased circulating plasma OPN (cOPN) precedes development of organ damage in pediat...
Autores principales: | Rullo, Ornella J, Woo, Jennifer MP, Parsa, Miriam F, Hoftman, Alice DC, Maranian, Paul, Elashoff, David A, Niewold, Timothy B, Grossman, Jennifer M, Hahn, Bevra H, McMahon, Maureen, McCurdy, Deborah K, Tsao, Betty P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672798/ https://www.ncbi.nlm.nih.gov/pubmed/23343383 http://dx.doi.org/10.1186/ar4150 |
Ejemplares similares
-
Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012) -
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022) -
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008) -
Ethnic differences in pediatric SLE early disease severity: a comparison between Hispanic-Americans and European-Americans
por: Liu, Peony, et al.
Publicado: (2012) -
Implementation of an electronic interface for the documentation of pediatric rheumatology medical records improves physician and patient utilization of time in clinic
por: Woo, Jennifer MP, et al.
Publicado: (2012)